• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - RCC
Tag:

RCC

Entertainment

Vidi Aldiano Kanker Ginjal: Penyebab & Faktor Risiko

by Chief Editor March 8, 2026
written by Chief Editor

Vidi Aldiano’s Battle and the Rising Concerns Around Kidney Cancer

The recent passing of Indonesian singer Vidi Aldiano after a six-year struggle with kidney cancer has brought renewed attention to this often-silent disease. Whereas Vidi’s story is deeply personal, it underscores a growing global health concern and prompts a crucial question: what factors contribute to kidney cancer, and what can be done to mitigate the risks?

Understanding the Genetic Roots of Kidney Cancer

According to specialists, kidney cancer typically develops due to genetic changes within kidney cells. These accumulated genetic alterations disrupt the normal control mechanisms governing cell growth and division. Dr. Andhika Rachman, a hematology-oncology consultant, explains that in the most common type, clear cell Renal Cell Carcinoma (RCC), alterations in the VHL (Von Hippel-Lindau) gene are frequently observed. This gene plays a role in activating pathways related to tumor growth and blood vessel formation.

Key Risk Factors: A Multifaceted Approach

While genetic predisposition is central, several lifestyle and environmental factors can significantly increase the risk of developing kidney cancer. These include:

  • Smoking: A well-established risk factor for numerous cancers, smoking likewise elevates the risk of kidney cancer.
  • Obesity: Higher body weight is linked to an increased risk.
  • Hypertension: High blood pressure is another contributing factor.
  • Family History: A family history of kidney cancer increases an individual’s susceptibility.
  • Chronic Kidney Disease & Dialysis: Long-term kidney disease and the need for dialysis are associated with a higher risk.
  • Chemical Exposure: Exposure to certain chemicals in occupational or residential settings can also play a role.

It’s important to note that possessing one or more of these risk factors doesn’t guarantee the development of kidney cancer. Dr. Andhika emphasizes that these factors increase the likelihood of genetic mutations that can lead to tumor formation, but don’t directly cause cancer.

Recognizing the Warning Signs

Early detection is crucial for successful kidney cancer treatment. Being aware of potential symptoms can prompt individuals to seek medical attention promptly. Key symptoms to watch for include:

  • Blood in the urine
  • Pain in the side, flank, or lower back
  • A lump in the abdomen or side
  • Unexplained weight loss
  • Persistent fatigue
  • Fever
  • Anemia
  • Bone pain or chronic cough (in advanced stages)

Future Trends in Kidney Cancer Research and Prevention

The medical community is continually striving to improve understanding, diagnosis, and treatment of kidney cancer. Several areas of research show promise:

Precision Medicine

Advances in genomic sequencing are paving the way for precision medicine approaches. By analyzing the specific genetic mutations driving an individual’s cancer, doctors can tailor treatment plans for maximum effectiveness.

Immunotherapy

Immunotherapy, which harnesses the body’s own immune system to fight cancer, has shown remarkable results in some kidney cancer patients. Ongoing research aims to expand the number of patients who respond to immunotherapy and to overcome resistance mechanisms.

Early Detection Biomarkers

Identifying biomarkers – measurable substances in the body – that can detect kidney cancer at its earliest stages is a major focus. This could lead to the development of non-invasive screening tests, similar to those used for other cancers.

FAQ: Kidney Cancer

What is the most common type of kidney cancer? Clear cell Renal Cell Carcinoma (RCC) is the most prevalent type.

Is kidney cancer hereditary? A family history of kidney cancer can increase risk, suggesting a genetic component, but it’s not always directly inherited.

Can kidney cancer be prevented? While not entirely preventable, adopting a healthy lifestyle – including not smoking, maintaining a healthy weight, and controlling blood pressure – can significantly reduce risk.

What should I do if I notice blood in my urine? Consult a doctor immediately. Blood in the urine can have various causes, and early diagnosis is essential.

What is the VHL gene? The VHL gene is often altered in clear cell RCC and plays a role in tumor growth.

Simak Video “Video: Klarifikasi Vidi Aldiano soal Kesehatannya hingga Disebut Pakai Wig“

The story of Vidi Aldiano serves as a poignant reminder of the importance of awareness, early detection, and ongoing research in the fight against kidney cancer. By understanding the risk factors and recognizing the symptoms, individuals can take proactive steps to protect their health.

March 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Business

Updated Data Support Axitinib Interruption and Avelumab Maintenance After Response in Advanced RCC

by Chief Editor February 15, 2025
written by Chief Editor

The Innovative Approach to Treating Metastatic Renal Cell Carcinoma

The recent phase 2 TIDE-A study results, presented at the 2025 Genitourinary Cancers Symposium, highlight a promising treatment strategy for metastatic renal cell carcinoma (RCC). By combining avelumab and axitinib and then strategically interrupting axitinib, patients saw significant benefits, with median progression-free survival (PFS) and overall survival (OS) remaining not reached. This approach of maintenance treatment and strategic interruption could revolutionize how we manage RCC, emphasizing the potential for personalized treatment schedules.

Strategic Interruption: A New Treatment Paradigm

Among the 29 patients who interrupted axitinib, both their median PFS and OS were not reached, with impressive 24-month survival rates of 58% and 82% respectively. This suggests that alternating between avelumab monotherapy and combination therapy allows the body to manage the disease more efficiently, potentially reducing wear from continuous treatment. The maintenance of avelumab monotherapy, even during disease progression, did not hinder the effectiveness of subsequent reinjections of axitinib, indicating a robust adaptability in treatment protocols.

Once Again, Precision in Cancer Care

This study reinforces the importance of precision in cancer treatment. The criteria for TIDE-A outline a specifically targeted group of metastatic RCC patients—measurable disease, ECOG performance status of 0 or 1, and no significant comorbidities—that benefited most from this innovative combination treatment. By tailoring treatments to specific patient responses and disease progressions, physicians can potentially extend treatment efficacy and patient survival rates.

Future Directions in RCC Treatment

With these findings, researchers advocate for further exploration through randomized clinical trials. This could pave the way for personalized treatment regimens, potentially lengthening both survival and quality of life for RCC patients. This method also presents a way to minimize adverse effects while maintaining or even improving therapeutic outcomes, suggesting a shift towards more patient-centric care.

Related Trends and Innovations

Emerging trends in cancer treatment increasingly reflect a shift towards immunotherapies and molecularly targeted therapies. The integration of avelumab and axitinib in the treatment of RCC underscores a broader movement away from one-size-fits-all approaches, focusing instead on maximizing patient outcomes through individualized care plans. This resonates with recent advancements in precision medicine, where treatments are increasingly tailored based on genetic, environmental, and lifestyle factors.

For example, precision oncology is making strides by using biomarkers to predict which cancer therapies will be most effective for each patient. This builds on the TIDE-A study’s principle of selectively using axitinib only when needed, maximizing therapeutic effects while minimizing potential side effects.

Frequently Asked Questions about Treating Metastatic RCC

FAQ

  • What makes the TIDE-A study unique?
    The TIDE-A study’s novel approach of maintaining avelumab monotherapy and interrupting axitinib has shown promise in extending PFS and OS in metastatic RCC patients, effectively reducing treatment load while maintaining disease management.
  • Could this treatment strategy be applied to other cancers?
    While specific to RCC in the TIDE-A study, the principle of adaptive treatment and strategic interruption has potential applications in other cancer types, warranting further investigation.
  • What are the key takeaways from the study?
    The study underscores the potential of combination therapies and personalized treatment adjustments to enhance patient outcomes in metastatic RCC.

Call to Action

Are you interested in the latest advancements in cancer treatment strategies? Explore more articles on our website. Stay informed about groundbreaking research and upcoming symposium insights. Subscribe to our newsletter for updates directly in your inbox.

Did you know? Personalized oncology treatments can now be designed using genetic profiling, offering a more targeted and effective approach to combating various types of cancer. Stay ahead of the curve by understanding the evolving landscape of cancer therapies.

Pro tip: Check out the recent developments in immunotherapy for other cancers, as the principles from the TIDE-A study could signify broader applications in oncology. For more in-depth information, visit Onclive.com.

February 15, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Inside the money machine of online casinos and gaming platforms turning play into profit

    May 5, 2026
  • Readers Speak: Vessel seizures top Hormuz risk

    May 4, 2026
  • All-you-can-drink Bali resort kids will go gaga over

    May 4, 2026
  • US to Assist Ships Trapped in Strait of Hormuz

    May 4, 2026
  • Trump: US to Assist Stuck Ships in Strait of Hormuz

    May 4, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World